Effect of Endothelin-1 on exercise-induced vasodilation in normal subjects and in patients with heart failure

American Journal of Cardiology

Volumn 81, Issue 3, 1998, Pages 355-358

  Krum, Henry ^a   Katz, Stuart D ^a,b  

^a Columbia Univ Coll of Phys and S ^*  (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; EXERCISE; FEMALE; FOREARM BLOOD FLOW; HAND GRIP; HEART DILATATION; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REST; VASODILATATION;

ADULT; BRACHIAL ARTERY; ENDOTHELIN-1; EXERCISE; EXERCISE TEST; FEMALE; FOREARM; HAND STRENGTH; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; REGIONAL BLOOD FLOW; VASODILATION;

EID: 0032005172     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00920-X     Document Type: Article

References (20)

1. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation Implications for vascular function . Circulation. 84:1991;1457-1468.
2. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 85:1992;504-509.
3. Krum H, Goldsmith R, Wilshire-Clement M, Miller M, Packer M. Role of endothelin in the exercise intolerance of chronic heart failure. Am J Cardiol. 75:1995;1282-1283.
4. Cavero PG, Miller WL, Heublein DM, Margulies KB, Burnett JCJ. Endothelin in experimental congestive heart failure in the anesthetized dog. Am J Physiol. 259:1990;F312-F317.
5. Katz SD, Krum H, Khan T, Knecht M. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure role of endothelium-derived nitric oxide . J Am Coll Cardiol. 28:1996;585-590.
6. Longhurst J, Capone RJ, Mason DT, Zelis R. Comparison of blood flow measured by plethysmograph and flowmeter during steady state forearm exercise. Circulation. 49:1974;535-540.
7. Nishimura H, Kubo S, Ueyama M, Kubota J, Kawamura K. Peripheral hemodynamic effects of captopril in patients with congestive heart failure. Am Heart J. 117:1989;100-105.
8. Haynes WG, Clarke JG, Cockcroft JR, Webb DJ. Pharmacology of endothelin-1 in vivo in humans. J Cardiovasc Pharmacol. 17:1991;S284-S286.
9. Kiowski W, Luscher TF, Linder L, Buhler FR. Endothelin-1-induced vasoconstriction in humans Reversal by calcium channel blockade but not by nitrovasodilators of endothelium-derived relaxing factor . Circulation. 83:1991;469-475.
10. B receptors cause vasoconstriction of human resistance and capacitance vesels in vivo. Circulation. 92:1995;357-363.
11. A receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation. 94:1996;2131-2137.
12. Fu LX, Sun XY, Hedner T, Feng QP, Liang QM, Hoebeke J, Hjalmarson A. Decreased density of mesenteric arteries but not of myocardial endothelin receptors and function in rats with ischemic heart failure. J Cardiovasc Pharmacol. 22:1993;177-182.
13. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci. 85:1988;9797-9800.
14. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH. Impaied endothelium-mediated vasodilation in the perpheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 19:1992;918-925.
15. Bonhomme M-C, Cantin M, Garcia R. Relaxing effect of atrial natriuretic factor on endothelin-precontracted vascular strips. Proc Soc Exp Biol. 191:1989;309-315.
16. Sharefkin JB, Diamond SL, Eskin SG, McIntire LV, Dieffenbach CW. Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J Vasc Surg. 14:1991;1-9.
17. de Groote P, Millaire A, Racadot A, Decoulx E, Ducloux G. Plasma levels of endothelin-1 at rest and after exercise in patients with moderate congestive heart failure. Int J Cardiol. 51:1995;267-272.
18. Miller VM, Burnett JCJ. Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. Am J Physiol. 263:1992;H103-H108.
19. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol. 258:1990;C408-C415.
20. Kiowski W, Sütch G, Hunziker P, Müller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence of endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 346:1995;732-736.